Evidence check: IgE in the context of Wechseljahre

The query concerns IgE in the context of menopause (Wechseljahre). The provided knowledge contexts contain no direct studies or mechanisms linking IgE levels specifically to menopause. IgE is well-established as a marker for allergic (type I hypersensitivity) responses, not hormonal changes. Some epidemiological data suggest that the decline in estrogen during menopause may influence immune regulation—for example, by shifting the Th1/Th2 balance—which could theoretically modulate IgE. However, the evidence is weak, inconsistent, and insufficient for clinical recommendations. IgE reference ranges are not stratified by menopausal stage. Direct-to-consumer tests marketing IgE as a 'menopause marker' lack validated scientific support. The Hallmarks of Aging discussion mentions chronic inflammation (inflammaging) but does not specifically address IgE. Therefore, the evidence level is best classified as 'unclear'. An IgE test is useful for allergy evaluation, but not for assessing menopausal status or associated symptoms. Patients should be informed of this limitation.